Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 3, 2010

Premium

Daniel Anderson, Charles Cooney, and Robert Langer have joined the scientific advisory board of Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals.

Anderson is a faculty member in the department of chemical engineering at the Massachusetts Institute of Technology's Division of Health Science Technology and the David H. Koch Institute for Integrative Cancer Research at MIT.

Cooney is the Robert T. Haslam professor of chemical and biochemical engineering and faculty director for the Deshpande Center for Technological Innovation at MIT. He is currently a director of Polypore International and Biocon, a principal at BioInformation Associates, and a director of Genzyme.

Langer is the David H. Koch Institute Professor at MIT and a member of the Institute of Medicine, the National Academy of Engineering, and the National Academy of Sciences.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.